Gadolinium-Based Contrast Safe for Patients With CKD Gadolinium-Based Contrast Safe for Patients With CKD

The risk for nephrogenic systemic fibrosis was low among patients with chronic kidney disease who received a gadolinium-based contrast agent, a study found.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Nephrology News Source Type: news